Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-05

Clinical Trial Update: Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trialUpdate on combining zonisamide with varenicline for nicotine dependence; completed phases 1 and 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • Zonisamide (zonisamide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Nicotine Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-05